Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Dina Chau"'
Autor:
John R. Teerlink, Fady I. Malik, Irene Agodoa, Mitchell A. Psotka, Dina Chau, Milena D. Anatchkova, Robyn von Maltzahn, Donald L. Patrick, John A. Spertus, Ingela Wiklund
Publikováno v:
JACC: Heart Failure. 4:791-804
Objectives The study sought to review the characteristics of existing patient-reported outcome (PRO) instruments used with chronic heart failure (HF) patients and evaluate their potential to support an approved U.S. Food and Drug Administration (FDA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc50e5b15422875d5b57bb1c581604f6
https://doi.org/10.1016/j.jchf.2016.04.010
https://doi.org/10.1016/j.jchf.2016.04.010
Autor:
Ajay Nirula, Philip J. Mease, J. Feng, Hema N. Viswanathan, Ngozi Erondu, Alex Mutebi, Mark C. Genovese, Dina Chau
Publikováno v:
The Journal of Rheumatology. 43:343-349
Objective.To evaluate the effect of brodalumab on psoriasis signs and symptoms assessed by the Psoriasis Symptom Inventory (PSI) in patients with psoriatic arthritis (PsA).Methods.This prespecified analysis of a phase II study (NCT01516957) evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdfbd72c9cbc9cffd8434f9a4be9304f
https://doi.org/10.3899/jrheum.150182
https://doi.org/10.3899/jrheum.150182
Autor:
Donald M. Bushnell, Hema N. Viswanathan, Mona L. Martin, Dina Chau, Lionel Pinto, Kenneth B. Gordon
Publikováno v:
The Journal of Dermatological Treatment
Introduction: The Psoriasis Symptom Inventory is a patient-reported outcome instrument that assesses severity of psoriasis signs and symptoms. In early qualitative research, patients reported pain related to psoriasis skin lesions and redness of affe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e53651944ee136044498cd2d3822a3
https://doi.org/10.3109/09546634.2014.996514
https://doi.org/10.3109/09546634.2014.996514
Autor:
Wenjjing Yang, Hema N. Viswanathan, Dennis A. Revicki, Paul Klekotka, Cassandra E Milmont, Ngozi Erondu, Dina Chau
Publikováno v:
Journal of Dermatological Treatment. 26:235-239
Newer therapies provide high levels of skin clearance in patients with moderate to severe psoriasis. However, insufficient evidence exists on the impact of total skin clearance from the patient's perspective.To examine effects of total skin clearance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a29d465e298b21ece476623803737992
https://doi.org/10.3109/09546634.2014.943687
https://doi.org/10.3109/09546634.2014.943687
Autor:
Alexa B. Kimball, Kenneth B. Gordon, Brian G. Ortmeier, Gregory Kricorian, Dina Chau, Joanne Li, Dennis A. Revicki, Hema N. Viswanathan
Publikováno v:
The British Journal of Dermatology
Background Psoriasis symptoms have a significant negative impact on health-related quality of life, impairing physical functioning and well-being. Objective To evaluate the impact of brodalumab, a human anti-interleukin-17R monoclonal antibody, on ps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e08df7f6c190d7bd539cce6a98d4ba09
https://doi.org/10.1111/bjd.12636
https://doi.org/10.1111/bjd.12636
Autor:
Mona L. Martin, Kelly P. McCarrier, Chiun-Fang Chiou, Kenneth Gordon, Alexa B. Kimball, Abby S. Van Voorhees, Alice B. Gottlieb, Xingyue Huang, Denise Globe, Dina Chau, Hema N. Viswanathan, Gregory Kricorian
Publikováno v:
Journal of Dermatological Treatment. 24:255-260
To develop and assess content validity of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome (PRO) measure of psoriasis symptoms.Following initial literature exploration and input from experts, concept elicitation was conducted in two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582ed4f04ea2f5dc31f4b832c21d80d4
https://doi.org/10.3109/09546634.2012.759639
https://doi.org/10.3109/09546634.2012.759639
Publikováno v:
Journal of Dermatological Treatment. 25:8-14
The psoriasis symptom inventory (PSI) is a patient-reported outcome measure for assessing symptom severity in patients with moderate-to-severe psoriasis. The primary objective of this study was to evaluate the measurement properties of the PSI.Analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572b67b41240a0ee596b03029ca2428b
https://doi.org/10.3109/09546634.2013.769042
https://doi.org/10.3109/09546634.2013.769042
Publikováno v:
Journal of Dermatological Treatment. 25:67-72
To describe biologic treatment patterns and effectiveness among patients with psoriasis who initiated biologic therapy.A chart review was conducted for 169 patients with psoriasis initiating biologic treatment between 1 July 2005 and 30 June 2009 fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bbb99c268c9ddf5249d7cf8d0a1b462
https://doi.org/10.3109/09546634.2013.768762
https://doi.org/10.3109/09546634.2013.768762
Autor:
Mitchell A, Psotka, Robyn, von Maltzahn, Milena, Anatchkova, Irene, Agodoa, Dina, Chau, Fady I, Malik, Donald L, Patrick, John A, Spertus, Ingela, Wiklund, John R, Teerlink
Publikováno v:
JACC. Heart failure. 4(10)
The study sought to review the characteristics of existing patient-reported outcome (PRO) instruments used with chronic heart failure (HF) patients and evaluate their potential to support an approved U.S. Food and Drug Administration (FDA) product la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8902d58330d7ace9a3332eaa2310bc86
https://pubmed.ncbi.nlm.nih.gov/27614943
https://pubmed.ncbi.nlm.nih.gov/27614943
Autor:
Donald L. Patrick, John R. Teerlink, Fady I. Malik, Milena D. Anatchkova, Hafiz Oko-Osi, Ingela Wiklund, Robyn von Maltzahn, Dina Chau, John A. Spertus
Publikováno v:
Health and Quality of Life Outcomes
Health and quality of life outcomes, vol 14, iss 1
Health and quality of life outcomes, vol 14, iss 1
Background Patient-reported outcome (PRO) measures can be used to support label claims if they adhere to US Food & Drug Administration guidance. The process of developing a new PRO measure is expensive and time-consuming. We report the results of qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f19469e978da4eb73b2b2c41a89f6d
https://pubmed.ncbi.nlm.nih.gov/27629389
https://pubmed.ncbi.nlm.nih.gov/27629389